Bee Vectoring Technologies International Inc. (BVT) is progressing into markets in North Africa and the Middle East through partnerships with locally-connected agribusinesses to commercialize the company’s proprietary bee vectoring system and biological control agent Clonostachys rosea strain CR-7 (CR-7).

BVT continues its strategic go-to-market collaborations in Turkey, Azerbaijan, Morocco and Israel.

In Turkey, the partnership is with BioGlobal: earlier this year, they ran demonstration trials with Turkey’s Ministry of Agriculture. Once the protocol is secured, BioGlobal will proceed with registration trials for CR-7 in Turkey, then move forward with full-country registration.

BVT is also collaborating with BioGlobal in Azerbaijan, where registration could be secured in as little as a year.

In Morocco, BVT has had successful trials on tomato crops; applying for country registration is the next step. BVT will work with Groupe SAOAS on the submission which is planned to be timed alongside the submission to the European Union.

In Israel, trials are being conducted with Lidorr Elements, a crop protection expert in the Israeli market. Lidorr Elements has commenced trials of CR-7 on almonds using the company’s bee vectoring system for bumblebees, comparing it with traditional spray applications. Trials on strawberry and tomato crops are planned next.

The next step is registering BVT’s technology and selling it to local growers in all four countries.

BVT’s addressable market in the four key countries includes 157,600 hectares of key crops grown. This includes an estimated 106,500 hectares of covered tomatoes, cherries and berries in Turkey; 8,100 hectares of covered tomatoes, covered apricots and berries in Azerbaijan; 22,000 hectares of covered tomatoes and berries in Morocco; and 31,000 hectares of almonds, tomatoes, peppers, berries, peaches and avocados in Israel.

READ MORE:
Bee Vectoring Technologies partners with Syensqo on new soybean seed applied technologies
Bee Vectoring Technologies, Inc. exploring potential sale
BVT announces paid demonstration trials in Mexico